These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9670107)

  • 1. Thrombolytic and antiplatelet action of xanthinol nicotinate (Sadamin): possible mechanisms.
    Bieroń K; Swies J; Kostka-Trabka E; Gryglewski RJ
    J Physiol Pharmacol; 1998 Jun; 49(2):241-9. PubMed ID: 9670107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of xanthinol nicotinate treatment on platelet aggregation.
    Seidel G; Endell W
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):139-43. PubMed ID: 844933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of "xanthinol niacinate" on platelet aggregation.
    Balkuv S; Akman N; Ulutin ON
    New Istanbul Contrib Clin Sci; 1967; 9(2):49-51. PubMed ID: 16300148
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative effects of placebo and plain and slow-release tablets of xanthinol nicotinate on exercise tolerance in normal human subjects.
    Sharma PL
    Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):19-21. PubMed ID: 631966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bioavailability and tolerance of xanthinol nicotinate depot preparations. Comparison of a conventional 500 mg xanthinol nicotinate depot tablet with new 500 mg and 1 g depot tablets].
    von Schrader HW; Buscher G; Dierdorf D; Freytag A; Mügge H; Wolf D
    Arzneimittelforschung; 1985; 35(9):1468-72. PubMed ID: 4084347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolytic activity of beta-adrenolytic drug, sotalol.
    Korbut R; Swies J; Marcinkiewicz E; Gryglewski RJ
    J Physiol Pharmacol; 1998 Mar; 49(1):51-60. PubMed ID: 9594410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The action of xanthinol nicotinate on the central and peripheral arterial pressure and on respiration in dogs].
    Mungiu OC; Topoliceanu F; Ionescu GD
    Rev Med Chir Soc Med Nat Iasi; 1991; 95(3-4):297-8. PubMed ID: 1823450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostacyclin and molsidomine synergise in their fibrinolytic and anti-platelet actions in patients with peripheral arterial disease.
    Bieroń K; Grodzińska L; Kostka-Trabka E; Gryglewski RJ
    Wien Klin Wochenschr; 1993; 105(1):7-11. PubMed ID: 8438599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The behaviour of haemodynamic indicators of pulmonary circulation and spirometric parametera under the influence of Sadamin in patients with chronic pulmonary heart syndrome].
    Horzela T; Dubiel JP; Dubiel JS; Szczeklik J; Zbigniew P; Karczmarz A; Mysik M
    Przegl Lek; 1975; 32(4):379-83. PubMed ID: 1129511
    [No Abstract]   [Full Text] [Related]  

  • 10. Calcitonin gene-related peptide-mediated antihypertensive and anti-platelet effects by rutaecarpine in spontaneously hypertensive rats.
    Li D; Peng J; Xin HY; Luo D; Zhang YS; Zhou Z; Jiang DJ; Deng HW; Li YJ
    Peptides; 2008 Oct; 29(10):1781-8. PubMed ID: 18625276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative evaluation of the wound-healing effect of benzofuracaine, etaden, and xanthinol nicotinate in an experiment].
    Stepaniuk GI; Ornostaĭ VV; Kozlov VG
    Patol Fiziol Eksp Ter; 1992; (3):16-8. PubMed ID: 1480413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vitro and in vivo effect of xanthinol niacinate on platelet aggregation, adhesion and blood coagulation.
    Balkuv S; Ulutin ON
    New Istanbul Contrib Clin Sci; 1967; 9(4):179-87. PubMed ID: 5609339
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacological properties and clinical use of xanthinol nicotinate].
    Mashkovskiĭ MD; Iuzhakov SD; Absava GI; Erokhina LG; Lebedeva NV
    Klin Med (Mosk); 1984 Nov; 62(11):30-4. PubMed ID: 6097742
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of the acetylosalicyd acid (ASA) and ticlopidine therapy on clinical condition and parameters of blood platelets in patients with peripheral arterial occlusive disease (PAOD)].
    Leo W; Westrych R; Bissinger A; Okraszewski J; Baj Z
    Pol Merkur Lekarski; 2007 Nov; 23(137):335-9. PubMed ID: 18361314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of Complamin on fibrinolysis and platelet aggregation in the aged].
    Matijević N; Sisić I; Korolija P; Pendić B
    Bilt Hematol Transfuz; 1980; 8(1):37-43. PubMed ID: 7337681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of the beta1-24 corticotropic hormone, angiotensin II and xanthinol nicotinate on the kinetics of aldosterone (author's transl)].
    Pinsker P; Bultasová H; Bláha V; Vavrejn B
    Cas Lek Cesk; 1977 Jan; 116(2):35-8. PubMed ID: 191194
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypotensive and antiaggregative effects of eugenosedin-B with serotonin and alpha/beta-adrenoceptor antagonistic activities in rats and human platelets.
    Shen KP; Chu LW; Hsieh SL; An LM; Chen IJ; Wu BN
    J Cardiovasc Pharmacol; 2008 Feb; 51(2):154-61. PubMed ID: 18287883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of beta1-24-corticotropic hormone, angiotensin II and xanthinol nicotinate on the kinetics of aldosterone.
    Pinsker P; Bultasová H; Bláha V; Vavrejn B
    Rev Czech Med; 1977; 23(4):206-13. PubMed ID: 201974
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological evaluation of xanthinol nicotinate (complamin).
    Galal E; Moustafa M; el-Gohary N; el-Mahdy SA; el-S Ali HI; Radwan AG
    J Egypt Med Assoc; 1976; 59(1-2):141-9. PubMed ID: 1032367
    [No Abstract]   [Full Text] [Related]  

  • 20. Xanthinol nicotinate in peripheral vascular disease.
    Davis E; Rozov H
    Practitioner; 1975 Dec; 215(1290):793-8. PubMed ID: 772653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.